Aclarion Earnings Estimate
| ACON Stock | USD 2.59 0.12 4.43% |
Aclarion Earnings per Share Projection vs Actual
About Aclarion Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Aclarion earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Aclarion estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Aclarion fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -46.1 M | -48.4 M | |
| Earnings Yield | (65.49) | (62.21) | |
| Price Earnings Ratio | (0.02) | (0.02) |
Pair Trading with Aclarion
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aclarion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclarion will appreciate offsetting losses from the drop in the long position's value.Moving together with Aclarion Stock
| 0.63 | OTC | Ocumetics Technology Corp | PairCorr |
| 0.68 | AHC | Austco Healthcare | PairCorr |
| 0.65 | 2DR | Inspire Medical Systems | PairCorr |
Moving against Aclarion Stock
| 0.79 | VMD | Viemed Healthcare | PairCorr |
| 0.66 | QIPT | Quipt Home Medical | PairCorr |
| 0.61 | 4DX | 4DMEDICAL | PairCorr |
| 0.42 | AMS | Advanced Medical Sol | PairCorr |
| 0.37 | TRLS | Trellus Health plc | PairCorr |
The ability to find closely correlated positions to Aclarion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aclarion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aclarion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aclarion to buy it.
The correlation of Aclarion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aclarion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aclarion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aclarion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclarion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Will Health Care Equipment & Supplies sector continue expanding? Could Aclarion diversify its offerings? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aclarion data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (12.12) | Revenue Per Share | Quarterly Revenue Growth 0.761 | Return On Assets | Return On Equity |
Investors evaluate Aclarion using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Aclarion's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Aclarion's market price to deviate significantly from intrinsic value.
Understanding that Aclarion's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aclarion represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Aclarion's market price signifies the transaction level at which participants voluntarily complete trades.